Leadless Cardiac Pacemaker Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Leadless Pacemaker Manufacturers and it is Segmented By Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Leadless Cardiac Pacemaker Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Leadless Cardiac Pacemaker Market Size

Leadless Cardiac Pacemaker Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 295.37 Million
Market Size (2030) USD 429.99 Million
CAGR (2025 - 2030) 7.80 %
Fastest Growing Market North America
Largest Market Asia-Pacific
Market Concentration High

Major Players

Leadless Cardiac Pacemaker Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Leadless Cardiac Pacemaker Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Leadless Cardiac Pacemaker Market Analysis

The Leadless Cardiac Pacemaker Market size is estimated at USD 295.37 million in 2025, and is expected to reach USD 429.99 million by 2030, at a CAGR of 7.8% during the forecast period (2025-2030).

The COVID-19 pandemic was an unprecedented health concern and adversely affected various surgical procedures, including cardiac surgery. To minimize the spread of the virus, the government imposed certain regularizations that led to a reduction in surgical procedures. Thus, the reduction of cardiac surgeries led to a decrease in demand for leadless pacemakers, impacting the Leadless Pacemakers Market and the Pacemaker Implantation Market initially during the COVID-19 pandemic. An article published in May 2022 by the National Library of Medicine reported that nationally there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases. The Mid-Atlantic region was most affected by the first COVID-19 surge, with a 69.7% reduction in overall case volume and an 80.0% reduction in elective cases. Thus, COVID-19 led to a reduction in cardiac surgical procedures, which affected the growth of the Leadless Pacemaker Market. Furthermore, the article published by the National Library of Medicine in February 2022 reported that in North America, 30.7% of the implantations included leadless pacemakers. Thus, with an increased rate of implantation of leadless pacemakers post pandemic as compared to the initial pandemic, the market is expected to regain its growth pace over the coming years.

The rising geriatric population, the growing burden of cardiovascular diseases, and technological advancements are expected to drive the Cardiac Pacemaker Market. According to the United Nations' World Population Aging Highlights 2022, there will be 771 million people aged 65 and over in the world in 2022. The older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. As a result, by 2050, there will be more than twice as many people aged 65 and up as children under the age of five. The number of persons aged 65 or over globally will be almost equal to that of those under 12 years of age. Furthermore, an article published by the National Library of Medicine in December 2021 reported that the incidence of cardiovascular diseases among patients aged 60 to 80 years was on average 75-78%, while in patients over 80 years of age the incidence exceeded 85%. According to the article, age is an unchangeable risk factor that is also considered an independent risk factor for atherogenesis and subsequent cardiovascular disease. Thus, the rising incidence of cardiac disease is driving the growth of the Cardiac Implants Market.

An increase in clinical trials of cardiac rhythm implant systems is expected to drive the Cardiac Rhythm Management Market. For instance, in December 2021, Boston Scientific launched a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator, two separate devices that aim to work together to keep the heart from beating too fast or too slowly. Such clinical trials are supposed to drive market growth.

Thus, factors such as the rising geriatric population and the growing burden of cardiovascular diseases are impacting the growth of the Leadless Cardiac Pacemaker Market and the overall Pacemaker Market. However, reimbursement issues are expected to restrain market growth.

Leadless Cardiac Pacemaker Industry Overview

The Leadless Cardiac Pacemaker Market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies with a significant market share, including leading Pacemaker Manufacturers USA such as Abbott Laboratories, Medtronic PLC, EBR Systems Inc., Boston Scientific Corporation, and MicroPort Scientific Corporation, among others.

Leadless Cardiac Pacemaker Market Leaders

  1. Abbott Laboratories

  2. Medtronic PLC

  3. EBR Systems Inc.

  4. Boston Scientific Corporation

  5. MicroPort Scientific Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Leadless Cardiac Pacemaker Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Leadless Cardiac Pacemaker Market News

  • February 2022 : as part of the AVEIR DR i2i pivotal clinical trial, Abbott revealed a dual-chamber leadless pacemaker device. The first patient in the pivotal study to receive Abbott's investigational Aveir dual-chamber leadless pacemaker marks a significant technological milestone for leadless pacing technology.
  • January 2022 : Medtronic plc received approval from Japan's Ministry of Health, Labor, and Welfare for the sale and reimbursement of the Micra AV Transcatheter Pacing System (TPS), and the company will launch the product in June 2022.

Leadless Cardiac Pacemaker Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Growing Burden of Cardiovascular Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Micra Transcatheter Pacing System
    • 5.1.2 Nanostim Leadless Pacemaker
    • 5.1.3 Others
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Medtronic PLC
    • 6.1.3 EBR Systems Inc.
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 MicroPort Scientific Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Leadless Cardiac Pacemaker Industry Segmentation

As per the scope of this report, a leadless cardiac pacemaker is a small, self-contained electrode system and generator that is implanted in the right ventricle. The device is placed via a femoral vein transcatheter technique. The Leadless Cardiac Pacemaker Market is segmented By Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Micra Transcatheter Pacing System
Nanostim Leadless Pacemaker
Others
By End User Hospitals
Ambulatory Surgical Centers
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Leadless Cardiac Pacemaker Market Research FAQs

How big is the Leadless Cardiac Pacemaker Market?

The Leadless Cardiac Pacemaker Market size is expected to reach USD 295.37 million in 2025 and grow at a CAGR of 7.80% to reach USD 429.99 million by 2030.

What is the current Leadless Cardiac Pacemaker Market size?

In 2025, the Leadless Cardiac Pacemaker Market size is expected to reach USD 295.37 million.

Who are the key players in Leadless Cardiac Pacemaker Market?

Abbott Laboratories, Medtronic PLC, EBR Systems Inc., Boston Scientific Corporation and MicroPort Scientific Corporation are the major companies operating in the Leadless Cardiac Pacemaker Market.

Which is the fastest growing region in Leadless Cardiac Pacemaker Market?

North America is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Leadless Cardiac Pacemaker Market?

In 2025, the Asia-Pacific accounts for the largest market share in Leadless Cardiac Pacemaker Market.

What years does this Leadless Cardiac Pacemaker Market cover, and what was the market size in 2024?

In 2024, the Leadless Cardiac Pacemaker Market size was estimated at USD 272.33 million. The report covers the Leadless Cardiac Pacemaker Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Leadless Cardiac Pacemaker Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Leadless Cardiac Pacemaker Industry Report

The report on the Leadless Pacemaker market provides a comprehensive industry analysis, covering various manufacturers and segmenting the market by product, end user, and geography. The report offers valuable industry information and industry outlook, with a detailed market forecast and market growth projections. It includes an industry overview and market segmentation, highlighting key market trends and market value. The report also features market data and market review, showcasing the market leaders and their contributions to the industry.

The industry reports include insights on the growth rate and market outlook, providing a clear picture of the industry's future. The report's industry research and market predictions are based on thorough market analysis and industry statistics. The research companies involved have compiled a report example that is available as a report PDF for further reference.

The market size and market share are extensively covered, giving an in-depth understanding of the market dynamics. The report also includes industry sales and industry size, providing a complete market overview. The market report highlights the market trends and market growth, ensuring that the readers are well-informed about the current and future state of the Leadless Pacemaker market.

In summary, this report serves as a valuable resource for anyone interested in the Leadless Pacemaker market, offering detailed insights and comprehensive industry research.